Ampersand wins £22m five-year contract at London Zoo
June 25, 2012
The FINANCIAL -- AstraZeneca’s Brilinta (ticagrelor) has been approved in the US to reduce the risk of stroke, a leading cause of disability ...
The FINANCIAL -- Roche today announced that the US Food and Drug Administration (FDA) has granted full approval of Venclexta® (venetoclax) ...